2014
DOI: 10.1016/j.athoracsur.2013.10.074
|View full text |Cite
|
Sign up to set email alerts
|

Venous Thromboembolism in Patients Undergoing Operations for Lung Cancer: A Systematic Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
46
1
2

Year Published

2014
2014
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(52 citation statements)
references
References 27 publications
3
46
1
2
Order By: Relevance
“…The VTE incidence after primary lung cancer surgery is 23.1%, which is much higher than that of benign lung diseases (10.2%). This finding is consistent with recent study (5). Lung cancer may be responsible for the higher incidence of thrombotic events associated with cancer, but do not reach statistical significance.…”
Section: Discussionsupporting
confidence: 83%
See 1 more Smart Citation
“…The VTE incidence after primary lung cancer surgery is 23.1%, which is much higher than that of benign lung diseases (10.2%). This finding is consistent with recent study (5). Lung cancer may be responsible for the higher incidence of thrombotic events associated with cancer, but do not reach statistical significance.…”
Section: Discussionsupporting
confidence: 83%
“…The surgery and tumor are the main causation of acquired hypercoagulability (1,2). The overall incidence of VTE after operation is approximately 0.8% to 1.6% (3,4), whereas the incidence of VTE after lung cancer surgery is higher than that, from 0.2% to 19% (5). A previous study show that the mortality rate of patients with VTE increase 6-fold, and half of the postoperative deaths are caused by VTE, about 2/3 VTE events occur before discharge (6).…”
Section: Introductionmentioning
confidence: 98%
“…Another recent systemic review by Christensen et al summarizing the results of 19 studies reported an overall risk of clinically detected VTE in patients undergoing operations for primary lung cancer to be as low as 2.0%, with the highest incidence present within 1 month of the operation (16). Despite analysing data from over 10,660 patients, all but one of the included studies were retrospective with marked heterogeneity, limiting the ability to pool the data.…”
Section: Discussionmentioning
confidence: 99%
“…Day et al recently reported a VTE rate of 1.2% for lower extremity arthroplasties, and only 0.53% for shoulder arthroplasties [60]. In a study of patients undergoing operations for lung cancer, on the other hand, Christensen et al reported a mean risk of 2.0% [61]. Stein et al report the rate of VTE in brain cancer patients, on the other hand, to be 3.5 diagnoses per 100 hospitalizations [15].…”
Section: Vte In Brain Tumor Patientsmentioning
confidence: 99%